Oct
2026
Fiera Milano, Italy
Visit us
stand 4J89, API

Nantong Jinghua Pharmaceutical co., Ltd.

Exhibitor at CPHI Milan 2026
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
  • No.20, 3 Haibin Road, Yanhai, Yanhai Economic Development Zone, Rudong, 226407, Nantong, Jiangsu, China
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 4J89, API

Products Featured at CPHI Milan 2026

  • Letermovir

    Product Letermovir

    use in prophylaxis of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell transplant patients. It is the first of a new class of CMV anti-infectives called DNA terminase complex inhibitors. 
  • INDOCYANINE GREEN

    Product INDOCYANINE GREEN

    Indocyanine green is a Diagnostic Dye. The mechanism of action of indocyanine green is as a Dye.
  • Phenobarbital

    Product Phenobarbital

    There are CEP and US DMF for this product, our main markets are regulatory market, such South America and European.
  • Fluorouracil

    Product Fluorouracil

    There are CEP certificate and US DMF, approved by TGA, FDA and COFERPIS.
  • Phenylbutazone

    Product Phenylbutazone

    There are CEP certificate and US VMF, approved by FDA for more than three years. Our main markets are European and US.